DEC 17, 2021 7:00 AM PST

Chronic Cannabis Use, Oral Microbiomes and the Link to Brain Disorders

WRITTEN BY: Kerry Charron

Long-term cannabis smoking can increase the risk of altering oral health and consequently brain heath. A recent study of cannabis’s effects on oral microbiomes found a correlation between chronic cannabis intake and increased levels of the bacteria Actinomyces meyeri. Researchers suspect that altering the oral microbiome causes underlying conditions for certain neurological disorders like dementia. Analysis of mouse saliva indicated that the disruption of the oral microorganisms led to increased migration of macrophages into the brain, and increased levels of beta-amyloid protein. Previous research studies found that elevated beta-amyloid protein levels were associated with impaired brain function, but this newly published study highlights the role cannabinoid consumption plays in modifying brain chemistry.

Smoking cannabis reduces the microbial diversity and good bacteria in the mouth which then increases the macrophages, which usually detect and destroy harmful organisms, that mistakenly trigger an autoimmune response in the brain characterized by inflammation. An overview of how THC’s anatomy affects the salivary glands sheds light on the oral microbiomes’ role in altering brain functioning. The salivary gland has a significant number of cannabinoid receptors. THC binds to these receptors and decreases saliva production. Researchers at The Medical University of South Carolina found that chronic cannabis consumption resulted in behavioral changes and increased beta-amyloid protein production in the brain. THC may have the same impact on saliva composition whether it is consumed by smoking or eating cannabis, but more research on oral microbiomes is needed to determine if there is a difference in risk factors associated with these two routes of administration.

Medical University of South Carolina immunologist Wei Wang, who led this study or oral microbiomes and cannabis use, stated, “That’s a puzzle. In general, people think that if you activate macrophages and they migrate to the brain, they produce proinflammatory signals that result in brain inflammation and eventually brain dysfunction. However, brain dysfunction can also occur without the conventional inflammatory signals.” His comments suggest future research will explore the function of cannabinoids in immune responses involved in gut-brain communication.

 

 

Sources: Eureka Science News AlertEBioMedicineNatureNIH

About the Author
BA and MA in English, MPS in Human Relations, and Ed.D. in Higher Education Administration
Kerry Charron writes about medical cannabis research. She has experience working in a Florida cultivation center and has participated in advocacy efforts for medical cannabis.
You May Also Like
MAY 02, 2022
Immunology
A Gene Defect That Causes Deadly Reactions to Viruses & Vaccines
MAY 02, 2022
A Gene Defect That Causes Deadly Reactions to Viruses & Vaccines
For many years, researchers have stressed the need to add diverse populations to genetic studies, which have often cente ...
MAY 08, 2022
Microbiology
A Relative of Some of the World's Deadliest Viruses is Found in Europe
MAY 08, 2022
A Relative of Some of the World's Deadliest Viruses is Found in Europe
African fruit bats are the natural hosts of Marburg and Ebola viruses, both of which are filoviruses. These RNA viruses ...
MAY 11, 2022
Drug Discovery & Development
Gene Therapy Shows Promise for Neuropathic Pain
MAY 11, 2022
Gene Therapy Shows Promise for Neuropathic Pain
A gene therapy has been able to inhibit neuropathic pain with no detectable side effects in mice with spinal cord and pe ...
MAY 20, 2022
Technology
Virtual reality & holograms will improve astronaut mental health during long-term space travel
MAY 20, 2022
Virtual reality & holograms will improve astronaut mental health during long-term space travel
Humans will be back on the Moon (Luna) within the next few years, and then on to Mars within the decade afterwards. We a ...
MAY 18, 2022
Immunology
COVID-19, MIS-C & Kawasaki Disease Lead to the Same Immune Response
MAY 18, 2022
COVID-19, MIS-C & Kawasaki Disease Lead to the Same Immune Response
The world has quickly learned that the SARS-CoV-2 virus causes COVID-19. But it can also cause another disorder in child ...
MAY 19, 2022
Drug Discovery & Development
Experimental Drug Shows Promise Against ALS
MAY 19, 2022
Experimental Drug Shows Promise Against ALS
A new experimental drug known as NU-9 may be more effective in treating ALS than existing FDA-approved drugs. The corres ...
Loading Comments...